AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Medical Letter on the CDC & FDA articles from June 2004

10,639 total articles

Set up an RSS feed
Close Set up an RSS feed that alerts you when new articles from Medical Letter on the CDC & FDA are available.
XML Add to My Yahoo! Add to My AOL Add to Google Subscribe in NewsGator
Frequently asked questions about RSS feeds
to find out when new articles for Medical Letter on the CDC & FDA arrive.

Medical Letter on the CDC & FDA archives from June 2004

Ascorbic acid corrects phenotype of Charcot-Marie-Tooth disease.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. "Charcot-Marie-Tooth disease (CMT) is the most common hereditary peripheral neuropathy, affecting 1...

Molecular epidemiology of hepatitis B and C infections in Asia reviewed.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Researchers review the molecular epidemiology of hepatitis B and C virus infections in Asia in a recent issue of Pediatrics International. "The present paper provides a review of the current...

Chronic liver disease mortality in the United States reported.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Researchers report the prevalence of chronic liver disease mortality in the United States in a recent issue of the journal Hepatology. "In 1998, chronic liver disease (CLD) was the tenth leading...

Pandemic influenza can be contained with antiviral agents.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Pandemic influenza can be contained with antiviral agents. According to recent research published in the American Journal of Epidemiology, "For the first wave of pandemic influenza or a...

Isonicotinic acid hydrazide inhibits malaria transmission in mosquito.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Isonicotinic acid hydrazide is an antituberculosis drug that inhibits malarial transmission in the mosquito gut. According to published research from England, "We studied the transmission-blocking...

Wild-type CCR5 confers HIV-1 cross-clade resistance.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Scientists describe risk associated HIV-1 cross-clade resistance of whole peripheral blood mononuclear cells from exposed uninfected individuals with wild-type CCR5. According to a study from the...

Maternal malaria and perinatal HIV transmission interaction complicated.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- The interaction between maternal malaria infection and perinatal HIV transmission is complicated. According to recent research from an international team of scientists, "To determine whether...

Components of HIV vaccine are recognized by T-helper cells.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Minor components of a multi-envelope HIV vaccine are recognized by type-specific T-helper cells. "HIV has thus far evaded control by vaccines, in part due to the high diversity among viral...

IL-15 may be beneficial for AIDS immunotherapy.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Interleukin-15 (IL-15) may be beneficial for AIDS immunotherapy. According to recent research published in the journal Trends in Immunology, "The current antiretroviral therapy has improved the...

Virus-like particles rich in HIV-1 envelope gp120 developed.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Researchers have developed virus-like particles rich in HIV-1 envelope gp120. "In order to improve the immunogenicity of HIV-1 envelope glycoproteins, we have fused gp120 to a carrier protein,...

Mice exposed to formaldehyde exhibit different inflammatory responses.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Researchers found differential immunogenic and neurogenic inflammatory responses in an allergic mouse model exposed to low levels of formaldehyde. "It is suspected that exposure to low levels of...

Animal studies used to determine risks of environmental toxicants.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Animal studies should be used with caution in determining risks of environmental toxicants. According to published research from the United States, "Toxicology studies using animals and in vitro...

Northwestern records on animal research inquiry subpoenaed by U.S. government.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- The U.S. Department of Health and Human Services has subpoenaed records related to Northwestern University's management and tracking of animals used in research, university officials said. The...

Membranal polypeptides of Bacillus anthracis identified.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Scientists have identified chromosomally encoded membranal polypeptides of Bacillus anthracis through a proteomic analysis. "Bacillus anthracis is the causative agent of anthrax disease....

Novel inhibitors of bacterial RNA polymerase I characterized.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Scientists have characterized novel inhibitors of bacterial RNA polymerase I. According to recent research from Italy, "GE 23077 factors A1, A2, B1, and B2 are novel antibiotics isolated from...

Antioxidant corrects neurobehavioral defect in ataxia-telangiectasia.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Treatment with a catalytic antioxidant corrects the neurobehavioral defect in ataxia-telangiectasia mice. According to a study from the United States, "Ataxia-telangiectasia is caused by mutations...

Avian influenza may be new pandemic threat.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Avian influenza may be a new pandemic threat. According to a study from the United States, "In December 2003, the largest outbreak of highly pathogenic avian influenza H5N1 occurred among poultry...

New FDA-approved catheter designed to treat shorter prostate lengths in BPH.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- TherMatrx, Inc., has received U.S. Food and Drug Administration approval to market a shorter length treatment catheter that will allow more patients to benefit from treatment with TherMatrx dose...

Flea-borne transmission model evaluates vaccines against bubonic plague.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- A flea-borne transmission model is useful for evaluating vaccine efficacy against naturally acquired bubonic plague. "A flea-to-mouse transmission model was developed for use in testing new...

Company submits IND to the FDA for ALS; announces the resignation of CEO.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Incara Pharmaceuticals Corp. (ICRA) has submitted an investigational new drug application (IND) with the U.S. Food and Drug Administration (FDA) to begin phase I clinical trials of AEOL 10150 for the...

WHO agency confirms efficacy of screening women 25-65 to reduce mortality.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- The International Agency for Research on Cancer (IARC), the cancer research arm of the World Health Organization, says screening women ages 25-65 for cervical cancer reduces their mortality risk from...

Incidence of chlamydial infection at all-time high in Washington state.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- The number of people in Washington state infected with chlamydia is at an all-time high, the Washington State Department of Health reports. Data show 16,796 people in Washington were diagnosed with...

Prevalence of chlamydial infection high among young adults in U.S.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Approximately 4% of young adults in the U.S. have chlamydial infection, with substantial racial/ethnic disparities present in the prevalence, a study has found. The sexually transmitted diseases...

Company launches colon cancer trial with GTI-2040.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Lorus Therapeutics, Inc., announced the initiation of a clinical trial of GTI-2040 in a novel combination with oxaliplatin and capecitabine in patients with advanced unresectable colon cancer. This...

Levels of aristolochic acids in Chinese herbs determined by NMR.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- The levels of aristolochic acids in Chinese herbs were determined by NMR. According to a study from the United States, "[superscript]1H NMR methodology for the simultaneous determination and...

4-methylthio-1-butyl group protects phosphate/thiophosphate groups.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- A thermolytic 4-methylthio-1-butyl group protects phosphate and thiophosphate groups during solid-phase synthesis of DNA oligonucleotides. According to a study from the United States, "The...

PPAR-alpha deficiency does not alter insulin sensitivity in mice.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Peroxisome proliferator-activated receptor-alpha deficiency does not alter insulin sensitivity in mice maintained on regular or high-fat diet. "Chronic peroxisome proliferator-activated receptor...

Reference materials program for dietary supplements outlined.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- The U.S. National Institutes of Health has released information about the development of analytical methods and the reference materials program for dietary supplements. "The need for validated...

FDA approves Vitrase for use as a spreading agent.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- ISTA Pharmaceuticals, Inc., (ISTA) announced that the U.S. Food and Drug Administration (FDA) has approved ISTA's new drug application (NDA) for Vitrase (hyaluronidase for injection; lyophilized, ovine)...

Ob/gyn group issues statement on FDA's non-approval of OTC status for Plan B.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- The following is a statement issued May 7, 2004, by Vivian M. Dickerson, MD, president of the ACOG American College of Obstetricians and Gynecologists, regarding the decision by U.S. Food and Drug...

CYP1A2 is not required for dioxin-induced immunosuppression.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- CYP1A2 is not required for 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced immunosuppression. According to a study from the United States, "One of the most sensitive and reproducible immunotoxic...

Comments on choice of human intraspecies uncertainty factors released.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Researchers comment on the selection of human intraspecies uncertainty factors in a recent issue of Human and Ecological Risk Assessment. "The Reference Dose (RID) is used in the risk assessment of...

Developmental pharmacology principles applied to environmental toxins.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- A scientist has applied the principles of developmental pharmacology to the study of environmental toxicants. "Although nontherapeutic xenobiotics represent the vast majority of environmental...

Mercury exposure and child development outcomes reviewed.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Scientists review mercury exposure and child development outcomes in a recent issue of the journal Pediatrics. According to researchers in the United States, "Mercury is ubiquitous in the global...

Vaccine-derived poliovirus isolated from stream waters in Hispaniola.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Circulating type 1 vaccine-derived poliovirus was isolated from sewage and stream waters in Hispaniola. "Twenty-one cases of acute flaccid paralysis (AFP) were reported on the island of Hispaniola...

Affinitak maker reports decrease in revenues during first quarter.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Isis Pharmaceuticals, Inc., (ISIS) announced its financial results for the first quarter of 2004. The company's revenue for the 3 months ended March 31, 2004, was $12.3 million compared to $14.0...

CardioSEAL maker announces increased first quarter revenue.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- NMT Medical, Inc., (NMTI), a company focused on designing, developing, and marketing minimally invasive solutions for the treatment of cardiac sources of stroke, announced financial results for the...

Arsenic determined in infant food products by IC-ICP-MS.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Scientists have designed a method for total arsenic determination and speciation in infant food products using ion chromatography-inductively coupled plasma-mass spectrometry. "Health risk...

Gene probes for quantifying Vibrio in crabmeat evaluated.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Scientists have evaluated two nonradioactive gene probes for the enumeration of Vibrio parahaemolyticus in crabmeat. "This study evaluated two nonradioactive DNA probe procedures for the detection...

Company receives first-to-file status on gabapentin tablets.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- IVAX Corp. (IVX) received final approval and confirmation of its first-to-file status from the U.S. Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for gabapentin...

Experts say hunger and AIDS create vicious cycle in Africa.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Hunger and AIDS have trapped millions of Africans in a spiral of sickness and death, experts told the U.S. Senate Foreign Relations Committee. "AIDS and hunger interact," said James Morris,...

WHO: More AIDS clinics needed in countries.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Small clinics should be opened across developing countries to treat HIV-infected people, boosting the onslaught against AIDS and helping improve general health, the World Health Organization (WHO) says....

HMS teams with MDwise to coordinate benefits for Medicaid managed care.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- MDwise, a managed care plan serving more than 100,000 Medicaid recipients in Indiana, has awarded Health Management Systems, Inc., a contract to provide coordination of benefits services. On behalf...

Role of noninvasive studies in risk for sudden cardiac death reviewed.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Scientists review the role of noninvasive studies in risk stratification for sudden cardiac death in a recent issue of Clinical Cardiology. According to a study from the United States, "Sudden...

Crimean-Congo hemorrhagic fever virus genome L RNA segment sequenced.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Scientists have determined the sequence of the Crimean-Congo hemorrhagic fever virus genome L RNA segment and encoded protein. "Sequence analysis of the L RNA genome segment and predicted encoded L...

Site provides information about hepatitis infection and therapy.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Researchers have developed an Internet site (Hep-Net) to provide information about hepatitis infection and therapy. "In Germany almost 1 million people are affected by chronic viral hepatitis....

Risk factors for hepatitis C in Alaska natives reported.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Researchers report the epidemiology and risk factors for hepatitis C in Alaska natives in a recent issue of the journal Hepatology. According to scientists in the United States, "Large cohorts of...

Immune responses in patients with hepatitis C and HIV described.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Scientists describe virus dynamics and immune responses during treatment in patients co-infected with hepatitis C and HIV. According to a study from the United States, "Mathematical modeling of the...

Hepatitis A/B vaccine cost-effective substitute for hepatitis B vaccine.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Substituting the bivalent hepatitis A/B vaccine for the hepatitis B in prisons in the United States would be cost-effective. According to a study from the United States, "Hepatitis B immunization...

Hepatitis vaccination in patients with chronic liver disease reviewed.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Scientists review hepatitis vaccination in patients with chronic liver disease in a recent issue of Alimentary Pharmacology and Therapeutics. According to a study from the United States, "Evidence...

Human herpesvirus-8 oral shedding higher without antiretroviral therapy.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Human herpesvirus-8 oral shedding is higher among HIV-infected men who are not receiving highly active antiretroviral therapy than among those receiving therapy. "Human herpesvirus-8 (HHV-8) is...

NDA submitted for nebivolol.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Mylan Laboratories, Inc., (MYL) announced that its branded-products subsidiary, Bertek Pharmaceuticals, Inc., has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA)...

CpG oligodeoxynucleotides find immunotherapeutic use.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- CpG oligodeoxynucleotides find immunotherapeutic use. "Synthetic oligodeoxynucleotides (ODNs) that contain immunostimulatory CpG motifs trigger an immunomodulatory cascade that involves B and T...

Annan to contact Libyan government over death sentences for six health workers.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Secretary-General Kofi Annan said he plans to contact the Libyan government "at a high level" about the death sentences for five Bulgarian nurses and a Palestinian doctor convicted of infecting hundreds...

Libyan protesters burn American flag to denounce U.S. criticism of AIDS trial.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Nearly 1,000 Libyans marched and burned an American flag to protest U.S. criticism of death sentences for 5 Bulgarian nurses and a Palestinian doctor accused of infecting hundreds of Libyan children...

Cross-talk between CD8+ and CD4+ T cells occurs in leishmaniasis.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- CD8+ T cells are required for optimal IFN-gamma production by CD4+ T cells in experimental cutaneous leishmaniasis. "Although the importance of CD8+ T cells for vaccination and immunity to...

Leishmaniasis in Brazil is a disease of urban-rural interface.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- American cutaneous leishmaniasis (ACL) in Brazil is a disease of the urban-rural interface. "American cutaneous leishmaniasis (ACL) was first reported from the south-western region of the state of...

Most hepatocellular carcinoma in West Africa caused by hepatitis B.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Most cases of hepatocellular carcinoma in West Africa are caused by infection with hepatitis B virus. According to an international team of researchers, "Hepatocellular carcinoma (HCC) is the most...

Circumsporozoite antigens quantified in Plasmodium-infected mosquitoes.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Scientists have quantified sporozoites and circumsporozoite antigen in mosquitoes infected with Plasmodium falciparum or P. vivax. According to published research from Brazil and the United States,...

Malaria sporozoites infect cells by two pathways.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Malaria sporozoites can infect cells by two pathways. According to a study from France, "Plasmodium sporozoite invasion of host hepatocytes is an initial key step of infection by the malaria...

Rare mutation in gene of P. falciparum isolates identified.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Scientists have identified a rare point mutation at C-terminus of merozoite surface antigen-1 gene of Plasmodium falciparum in eastern Indian isolates. According to a study from India, "Merozoite...

Genotypes of malaria-infected patients in Papua New Guinea reported.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Researchers have determined the distribution of msp2 genotypes among symptomatic and asymptomatic individuals infected with Plasmodium falciparum from the Wosera region of Papua New Guinea. ...

Plasmodium falciparum peptides bind to human hepatocytes.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Sporozoite and liver stage antigen Plasmodium falciparum peptides bind specifically to human hepatocytes. According to recent research from Colombia, "Sporozoite and Liver Stage Antigen (SALSA)...

Plasmodium gametocyte stages neglected in vaccine development.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Plasmodium vivax and Plasmodium falciparum gametocyte stages are neglected in malaria vaccine development. "Plasmodium gametocytes are responsible for transmission from the vertebrate host to the...

Displacement in 6725 SERA peptide analogue protects against malaria.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Induction and displacement of an alpha helix in the 6725 SERA peptide analogue confers protection against Plasmodium falciparum malaria. "The protein called serine repeat antigen (SERA) is a P....

Malaria vaccine results indicate protection related to antibody levels.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Immunization of Saimiri sciureus monkeys with Plasmodium falciparum merozoite surface protein-3 and glutamate-rich protein suggests that protection is related to antibody levels. "The...

Response to conserved epitope linked to protection from malaria.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. According to a study from...

Vaccine genes of P. falciparum during hepatic phase identified.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Researchers have determined the transcription status of vaccine candidate genes of Plasmodium falciparum during the hepatic phase of its life cycle. "The CSP, EMP2/MESA, MSP2, MSP3, MSP5, RAP1,...

X-ray analysis conducted on protein vaccine candidate for malaria.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Scientists have conducted a preliminary X-ray analysis of the Plasmodium vivax sexual stage 25-kDa protein Pvs25, a transmission-blocking vaccine candidate for malaria. According to a study from...

Aerosol better than subcutaneous delivery for measles booster.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Researchers have performed immunologic studies of specific mucosal and systemic immune responses in Mexican school children after booster aerosol or subcutaneous immunization with measles vaccine. ...

Human metapneumovirus infection similar in severity to RSV in children.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Human metapneumovirus infection is similar in severity to respiratory syncytial virus (RSV) among children hospitalized with acute respiratory illness. According to published research from the...

Presence of certain eye disorders linked with poorer survival rates.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Individuals with age-related macular degeneration (AMD) and cataract may have a decreased life span compared to those without these eye disorders, suggesting that these conditions may also reflect other...

Animal studies show promise treating severe chronic pain.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Researchers may be on the trail of a new and more targeted treatment for severe chronic pain. A team of scientists recently established in a series of animal studies the therapeutic potential of...

No link found between IGF or IGF-binding protein and pancreatic cancer.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- No association existed between insulin-like growth factor (IGF)-1 or IGF-binding protein-3 and pancreatic cancer in male smokers. According to recent research published in the journal Cancer...

Predictors of pneumococcal carriage and resistance in children reported.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Researchers report the community-level predictors of pneumococcal carriage and resistance in young children. According to published research from the United States, "Pneumococcal carriage and...

Vaccine reduces racial disparity in incidence of childhood pneumonia, meningitis.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- A vaccine that was distributed beginning in 2000 has reduced the incidence of childhood pneumonia and meningitis and has helped to decrease the excess incidence among black Americans, according to a new...

Two pneumococcal vaccines safe and effective in American Indian infants.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Results from a pilot study indicated that two octavalent pneumococcal conjugate vaccines are safe and effective in American Indian infants. "We evaluated the safety and immunogenicity of two...

Women suffering brunt of conflict in Western Sudan, UNFPA warns.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Continuing violence and displacement in the Darfur region of western Sudan are having devastating consequences for hundreds of thousands of women and girls, the United Nations Population Fund (UNFPA),...

Model to assess risk of non-ionizing pulsed radiation developed.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Scientists have developed a model to assess the risk posed by non-ionizing pulsed radiation exposure. "The increasing use of digital technologies such as mobile phones has led to major health...

Protein folding 'speed limit' estimated.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Scientists estimate the protein folding 'speed limit' to be N/100 microseconds. "How fast can a protein possibly fold? This question has stimulated experimentalists to seek fast folding proteins and...

Cost analysis of bike and pedestrian trails outlined.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Scientists report a cost analysis of bike and pedestrian trails in Lincoln, Nebraska in a recent issue of the American Journal of Public Health. According to a study from the United States, "We...

Methods for ranking cities by public health criteria reported.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Scientists review methodology for ranking cities according to public health criteria in a recent issue of the American Journal of Public Health. According to published research from the United...

Studies show success of Mectizan partnerships.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- The development of the drug Mectizan (ivermectin) and its distribution worldwide have radically altered the consequences of onchocerciasis, or river blindness, which once blinded millions in Africa and...

Rubella in developing countries still causing blindness and deafness.
June 6, 2004... 2004 JUN 6 - (NewsRx.com & NewsRx.net) -- Rubella in developing countries continues to cause blindness and deafness. According to a study from England, "Maternal rubella is now rare in many developed countries that have rubella vaccination...

More articles from Medical Letter on the CDC & FDA: 1 | 2 | 3 | 4 | 5
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA